Literature DB >> 27113133

Proteomics strategies for bipolar disorder evaluation: From sample preparation to validation.

Jemmyson Romário de Jesus1, Gustavo de Souza Pessôa2, Alessandra Sussulini2, José Luis Capelo Martínez3, Marco Aurélio Zezzi Arruda4.   

Abstract

Bipolar disorder (BD) is a complex and costly psychiatric disorder, which affects one hundred million people worldwide. Due to its heterogeneity, correct BD diagnosis is still a challenge. In order to overcome this issue, different bioanalytical strategies have been proposed in the literature recently. Among these strategies, proteomic approaches have arisen as some of the most promising in the area. Thus, recent applications suggest protein profiles to further refine the proteome of BD as well as the discovery of novel protein biomarkers to facilitate diagnostics. In this review, the state-of-art of proteomic research in BD is summarized. Furthermore, important aspects of proteomics for understanding of BD, such as sample type and size, sampling, sample preparation, gel-based and gel-free proteomics, proteomic quantitative and protein validation are overviewed.

Entities:  

Keywords:  Analytical proteomics; Biomarkers; Diagnosis; Mental illness; Sequence of analysis

Mesh:

Substances:

Year:  2016        PMID: 27113133     DOI: 10.1016/j.jprot.2016.04.034

Source DB:  PubMed          Journal:  J Proteomics        ISSN: 1874-3919            Impact factor:   4.044


  1 in total

Review 1.  Proteomics for blood biomarker exploration of severe mental illness: pitfalls of the past and potential for the future.

Authors:  Ashley L Comes; Sergi Papiol; Thorsten Mueller; Philipp E Geyer; Matthias Mann; Thomas G Schulze
Journal:  Transl Psychiatry       Date:  2018-08-16       Impact factor: 6.222

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.